May 18 (Reuters) – Agile Therapeutics Inc said on
Friday it is looking for ways to fund operations after U.S.
health regulators suggested that a new clinical trial may be
required to test the company’s stick-on contraceptive patch.

Read More At Article Source | Article Attribution